«Sanofi-Synthelabo Pharmaceuticals Incorporated

Below is an extended Sanofi-Synthelabo Pharmaceuticals Incorporated news listing. Click here to return to the Sanofi-Synthelabo Pharmaceuticals Incorporated main Biocorporate entry.

BioNews Results for Sanofi-Synthelabo Pharmaceuticals Incorporated:
Evolution of Lipid Therapy: Combination Therapy and the Changing Landscape of CV Risk Reduction Medscape: Oct 3 2008 10:45PM Matching: sanofi synthelabo pharmaceuticals
Brain teasers Express Pharma: Sep 26 2008 6:32AM Matching: sanofi synthelabo pharmaceuticals
Sanofi-Aventis Acquires Zentiva For $2.6B Pharmaceutical Online: Sep 24 2008 11:51AM Matching: sanofi synthelabo pharmaceuticals
Managing Developmental Transitions in ADHD: Interdisciplinary Collaboration to Improve Care Abstracts in Hematology and Oncology: Sep 11 2008 7:12PM Matching: sanofi synthelabo pharmaceuticals

Home Marketing Services News Reports Company Profiles InDepth Drug Discovery Careers Conferences Videos Search Contact
	Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner. See User Agreement Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472	All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10 Copyright 1997-2008 - BioPortfolio Limited.